Dr Melissa Lynn Mckittrick, MD | |
3400 Lebanon Rd, Murfreesboro, TN 37129-1392 | |
(615) 225-2522 | |
Not Available |
Full Name | Dr Melissa Lynn Mckittrick |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 3400 Lebanon Rd, Murfreesboro, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174056428 | NPI | - | NPPES |
Entity Name | Vanderbilt University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
A team of genomic researchers headed by biologists at New York University's Center for Comparative Functional Genomics, in collaboration with researchers at Harvard University, the Max Planck Institute, and Cenix Biosciences, has mapped out a preliminary molecular diagram of the early stages of embryo formation, offering for the first time a global look at how a single cell begins its path into a multi-cellular organism.
Genzyme Corp. has announced that it has filed with the U.S. Food and Drug Administration (FDA) for approval of Synvisc-One, the single treatment of Synvisc (hylan G-F 20) that provides up to six months of pain relief from osteoarthritis (OA) of the knee.
In 2004 University of Kansas researchers Linda Heitzman-Powell and Jay Buzhardt had the bold idea of training parents of children with autism to use an intervention based on the science of applied behavior analysis (ABA) to help them increase their children's independent skills and reduce problem behaviors.
A team of international scientists has recently demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is currently available on the bioRxiv* preprint server.
UNC Lineberger Comprehensive Cancer Center researcher Barbara Savoldo, MD, PhD, was awarded a $600,000, three-year grant from The Leukemia & Lymphoma Society to support research into an immunotherapy treatment being developed with a "safety switch" to safeguard against potential side effects of the treatment.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Melissa Lynn Mckittrick, MD 1310 Fatherland St, Nashville, TN 37206-2910 Ph: (913) 486-6876 | Dr Melissa Lynn Mckittrick, MD 3400 Lebanon Rd, Murfreesboro, TN 37129-1392 Ph: (615) 225-2522 |
News Archive
A team of genomic researchers headed by biologists at New York University's Center for Comparative Functional Genomics, in collaboration with researchers at Harvard University, the Max Planck Institute, and Cenix Biosciences, has mapped out a preliminary molecular diagram of the early stages of embryo formation, offering for the first time a global look at how a single cell begins its path into a multi-cellular organism.
Genzyme Corp. has announced that it has filed with the U.S. Food and Drug Administration (FDA) for approval of Synvisc-One, the single treatment of Synvisc (hylan G-F 20) that provides up to six months of pain relief from osteoarthritis (OA) of the knee.
In 2004 University of Kansas researchers Linda Heitzman-Powell and Jay Buzhardt had the bold idea of training parents of children with autism to use an intervention based on the science of applied behavior analysis (ABA) to help them increase their children's independent skills and reduce problem behaviors.
A team of international scientists has recently demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is currently available on the bioRxiv* preprint server.
UNC Lineberger Comprehensive Cancer Center researcher Barbara Savoldo, MD, PhD, was awarded a $600,000, three-year grant from The Leukemia & Lymphoma Society to support research into an immunotherapy treatment being developed with a "safety switch" to safeguard against potential side effects of the treatment.
› Verified 8 days ago
Eric Young, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Dr, Murfreesboro, TN 37129 Phone: 161-589-3448 | |
Dr. Stephanie Petrina Noack, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Dr, Murfreesboro, TN 37129 Phone: 615-893-4480 | |
Gregory Bryan Terry, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Kenneth F Caissie, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Andrew M Wright, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 330, Murfreesboro, TN 37129 Phone: 615-396-4464 Fax: 615-396-6748 | |
Shyam A Jha, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 528 N University St, Murfreesboro, TN 37130 Phone: 615-968-7727 Fax: 615-467-8587 |